A Study of ALS-008176 in Infants and Children Hospitalized with RSV

Registry ID

EUCTR2016-001641-79

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

Janssen-Cilag International NV

Start date

2016-06-22

Completion date

2017-03-30

Last update

2026-08-16

Conditions

• Respiratory Syncytial Virus Infection

Summary

The primary objective is to determine in infants and children who are hospitalized with RSV infection the dose-response relationship of multiple regimens of ALS-008176 on antiviral activity based on nasal RSV shedding using quantitative real-time reverse transcriptase polymerase chain reaction [qRT-PCR] assay.

Locations

• , , UK

Related clinical trials

• Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
• A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children
• Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )

View on source registry